| Literature DB >> 31615522 |
Manoj Chandrabose1,2, Ester Cerin3,4,5, Suzanne Mavoa3,6, David Dunstan3,4, Alison Carver3, Gavin Turrell7,8, Neville Owen9,4,6,10,11,12, Billie Giles-Corti7, Takemi Sugiyama3,9,4.
Abstract
BACKGROUND: Living in walkable neighborhoods may provide long-term cardio-metabolic health benefits to residents. Little empirical research has examined the behavioral mechanisms in this relationship. In this longitudinal study, we examined the potential mediating role of physical activity (baseline and 12-year change) in the relationships of neighborhood walkability with 12-year changes in cardio-metabolic risk markers.Entities:
Keywords: Built environment; Cardiovascular disease; Hypertension; Pathways; Population health; Type 2 diabetes
Mesh:
Year: 2019 PMID: 31615522 PMCID: PMC6792258 DOI: 10.1186/s12966-019-0849-7
Source DB: PubMed Journal: Int J Behav Nutr Phys Act ISSN: 1479-5868 Impact factor: 6.457
Fig. 1Relationships of walkability with changes in cardio-metabolic risk markers (a), mediated through the baseline and the change in physical activity (b)
Baseline characteristics of study participants, AusDiab study, 1999–2000, (N = 2023)
| Baseline characteristics | Means (SD) or Percentages |
|---|---|
| Age, years | 49.8 (10.2) |
| Gender, % Women | 54.5 |
| Education | |
| % High school or less | 33.1 |
| % Technical or vocation | 43.1 |
| % Bachelor’s degree or more | 23.8 |
| Employment status | |
| % Working | 74.3 |
| % Not working | 25.1 |
| % Others | 0.6 |
| Weekly household income | |
| % Less than $600 | 27.4 |
| % $600–1500 | 48.0 |
| % > $1500 | 24.7 |
| Marital status, % couple | 86.1 |
| Children in household, % yes | 48.3 |
| Cardio-metabolic risk markers | |
| WC (cm) | 88.7 (13.1) |
| Weight (kg) | 75.5 (15.4) |
| SBP (mmHg) | 127.0 (16.7) |
| DBP (mmHg) | 70.4 (11.3) |
| FPG (mg/dL) | 98.7 (17.6) |
| 2-h PG (mg/dL) | 107.3 (35.6) |
| HDL-C (mg/dL) | 55.9 (14.6) |
| TG (mg/dL) | 127.8 (87.4) |
| Total physical activity (hours/week) | 5.0 (6.1) |
| Walking (hours/week) | 2.1 (2.7) |
| Moderate-intensity physical activity (hours/week) | 1.0 (2.7) |
| Vigorous-intensity physical activity (hours/week) | 0.9 (2.0) |
| Medication use (reported at least at one wave) | |
| For hypertension, % yes | 32.1 |
| For type 2 diabetes (including insulin), % yes | 4.8 |
| For high cholesterol, % yes | 23.5 |
| Family history of diabetes (pooled across waves), % yes | 29.0 |
| Index of Relative Socioeconomic Disadvantage (2011 Census) | 1021.4 (58.6) |
Abbreviations: WC Waist Circumference, SBP Systolic Blood Pressure, DBP Diastolic Blood Pressure, FPG Fasting Plasma Glucose, 2-h PG 2-h Postload Plasma Glucose, HDL-C High-Density Lipoprotein Cholesterol, TG Triglycerides
Descriptive statistics for walkability and its components within participants’ 1 km street-network residential buffers, AusDiab study, 1999–2012, (N = 2023)
| Walkability components | Mean (SD) | Min | Q1 | Median | Q3 | Max | Correlation Matrix | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Res. density | Int.density | Des.density | Walkability | |||||||
| Res. density a | 7.1 (3.6) | 0.1 | 4.5 | 6.6 | 9.4 | 26.2 | 1.0 | 0.6* | 0.4* | 0.8* |
| Int. density b | 4.0 (4.5) | 0.0 | 0.8 | 2.3 | 5.2 | 20.7 | 1.0 | 0.4* | 0.8* | |
| Des. density c | 1.5 (1.5) | 0.0 | 0.0 | 1.2 | 2.3 | 8.1 | 1.0 | 0.7* | ||
| Walkability | 0.0 (1.0) | −1.6 | −0.7 | − 0.2 | 0.6 | 5.1 | 1.0 | |||
Abbreviations: Res Residential, Int Intersections, Des Destinations;
*P < 0.001
aNumber of dwellings/hectare within 1 km of each residence
bNumber of 4-way intersections/km2 within 1 km of each residence
cNumber of daily living destinations/km2 within 1 km of each residence
Mean changes cardiometabolic risk markers, AusDiab study, 1999–2012, (N = 2023)
| Cardiometabolic | No of participants included in models | Mean (95% CI) change from AusDiab1 to 3 | Meana (95% CI) annual change |
|---|---|---|---|
| WC (cm) | 2023 | 5.35 (5.02, 5.67) | 0.45 (0.42, 0.47) |
| Weight (kg) | 2019 | 2.25 (1.95, 2.54) | 0.18 (0.16, 0.21) |
| SBP (mmHg) | 2019 | 3.00 (2.25, 3.74) | 0.30 (0.24, 0.36) |
| DBP (mmHg) | 2019 | 2.20 (1.66, 2.74) | 0.20 (0.16, 0.25) |
| FPG (mg/dL) | 2023 | −0.08 (− 0.93, 0.77) | 0.01 (− 0.06, 0.08) |
| 2-h PG (mg/dL) | 1997 | 1.97 (0.39, 3.56) | 0.15 (0.02, 0.29) |
| HDL-C (mg/dL) | 2023 | 3.58 (3.12, 4.05) | 0.31 (0.27, 0.35) |
| TG (mg/dL) | 2023 | −10.24 (− 13.54, −6.94) | −0.87 (− 1.15, − 0.6) |
Abbreviations: WC Waist Circumference, SBP Systolic Blood Pressure, DBP Diastolic Blood Pressure, FPG Fasting Plasma Glucose, 2-h PG 2-h Postload Plasma Glucose, HDL-C High-Density Lipoprotein Cholesterol, TG Triglycerides
aEstimated from the unconditional growth model
Total effects of walkability index on annual changes in cardio-metabolic risk markers, AusDiab study, 1999–2012, (N = 2023)
| Cardio-metabolic risk marker | ||
|---|---|---|
| WC (cm) | −0.02 (− 0.05, 0.00) | 0.092 |
| Weight (kg) | −0.03 (− 0.05, 0.00) |
|
| SBP (mmHg) | −0.15 (− 0.21, − 0.08) |
|
| DBP (mmHg) | 0.01 (− 0.03, 0.05) | 0.552 |
| FPG (mg/dL) | −0.06 (− 0.13, 0.00) | 0.053 |
| 2-h PG (mg/dL) | 0.01 (− 0.11, 0.14) | 0.826 |
| HDL-C (mg/dL) | −0.06 (− 0.10, − 0.02) |
|
| TG (mg/dL) | 0.04 (− 0.18, 0.26) | 0.702 |
Abbreviations: WC Waist Circumference, SBP Systolic Blood Pressure, DBP Diastolic Blood Pressure, FPG Fasting Plasma Glucose, 2-h PG 2-h Postload Plasma Glucose, HDL-C High-Density Lipoprotein Cholesterol, TG Triglycerides
Models adjusted for baseline age, gender, education, baseline work status, baseline household income, baseline marital status, baseline household children status, changes in socio-demographic factors (work status, household income, marital status, and household children status), height (only for weight), hypertension medication use (for SBP and DBP only), treatment for diabetes and family history of diabetes (for FPG and 2-h PG only), cholesterol medication use (for HDL-C and TG only), and Index of Relative Socio-economic Disadvantage. Regression coefficients correspond to 1 SD increment in walkability index. P-value < 0.05 in boldface
Relationships of the baseline and the annual change in physical activity with annual changes in cardio-metabolic risk markers, adjusted for walkability index, AusDiab study, 1999–2012 (N = 2023)
| Cardio-metabolic risk markers | ||||
|---|---|---|---|---|
| Baseline physical activity (hours/week) | Change in physical activity (hours/week) | |||
| WC (cm) | −0.008 (− 0.014, − 0.002) |
| −0.096 (− 0.139, − 0.053) |
|
| Weight (kg) | −0.006 (− 0.011, − 0.001) |
| −0.056 (− 0.094, − 0.017) |
|
| SBP (mmHg) | −0.001 (− 0.013, 0.012) | 0.926 | 0.023 (− 0.070, 0.116) | 0.624 |
| DBP (mmHg) | −0.004 (− 0.011, 0.004) | 0.372 | −0.058 (− 0.116, 0.000) | 0.050 |
| FPG (mg/dL) | −0.005 (− 0.016, 0.006) | 0.382 | −0.099 (− 0.181, − 0.016) |
|
| 2-h PG (mg/dL) | −0.011 (− 0.038, 0.015) | 0.397 | −0.155 (− 0.354, 0.044) | 0.126 |
| HDL-C (mg/dL) | 0.012 (0.004, 0.020) |
| 0.158 (0.095, 0.221) |
|
| TG (mg/dL) | −0.028 (− 0.074, 0.018) | 0.236 | − 0.516 (− 0.863, − 0.169) |
|
Abbreviations: WC Waist Circumference, SBP Systolic Blood Pressure, DBP Diastolic Blood Pressure, FPG Fasting Plasma Glucose, 2-h PG 2-h Postload Plasma Glucose, HDL-C High-Density Lipoprotein Cholesterol, TG Triglycerides. Models adjusted for walkability index, baseline age, gender, education, baseline work status, baseline household income, baseline marital status, baseline household children status, changes in lifestyle factors (work status, household income, marital status, and household children status), height (only for weight), hypertension medication use (for SBP and DBP only), treatment for diabetes and family history of diabetes (for FPG and 2-h PG only), cholesterol medication use (for HDL-C and TG only), and Index of Relative Socio-economic Disadvantage. P-value < 0.05 in boldface